Loading
Latest filing published 20 Sept 2022 for MedMen Enterprises, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Melvin Elias, listed as board member, appears in our data through filings on MedMen Enterprises, Inc. shares, published by SEC (Form 4). The record holds 6 filings, for trades running from 23 November 2020 to 19 April 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 20 September 2022: a share grant, in MedMen Enterprises, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations